Use of Continuous Glucose Monitoring and Glucagon-Like Peptide 1 Receptor Agonist Therapy to Achieve Individualized Treatment Goals in Insulin-Treated People With Type 2 Diabetes: A Case Series and Expert Opinion.

Ehrhardt, Nicole M; Aroda, Vanita R; Galindo, Rodolfo J; Peters, Anne L; Shubrook, Jay H

Ehrhardt, Nicole M; Aroda, Vanita R; Galindo, Rodolfo J; Peters, Anne L; Shubrook, Jay H.

Afiliação

Ehrhardt NM; University of Washington Medicine Diabetes Institute, Seattle, WA.
Aroda VR; Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Galindo RJ; Diabetes Research Institute, University of Miami Health System, Miami, FL.
Peters AL; Keck School of Medicine of the University of Southern California, Los Angeles, Los Angeles, CA.
Shubrook JH; College of Osteopathic Medicine, Touro University California, Vallejo, CA.

Clin Diabetes ; 42(2): 341-350, 2024.

Article em En | MEDLINE | ID: mdl-38666194

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin Diabetes Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin Diabetes Ano de publicação: 2024 Tipo de documento: Article